Black Diamond Therapeutics, Inc. (BDTX)
2.67
+0.12
(+4.71%)
USD |
NASDAQ |
Dec 24, 16:00
Black Diamond Therapeutics Free Cash Flow: 21.35M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 20.46B |
| Puma Biotechnology, Inc. | 42.87M |
| Cidara Therapeutics, Inc. | -132.94M |
| Oric Pharmaceuticals, Inc. | -119.64M |
| Acumen Pharmaceuticals, Inc. | -123.74M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.85M |
| Cash from Investing (Quarterly) | 8.59M |
| Cash from Financing (Quarterly) | 0.134M |
| Free Cash Flow Per Share (Quarterly) | -0.1379 |
| Free Cash Flow to Equity (Quarterly) | -6.768M |
| Free Cash Flow to Firm (Quarterly) | -7.85M |
| Free Cash Flow Yield | 14.03% |